Description:

Cardiometabolic disorders are the leading cause of morbidity and mortality yet can largely be prevented with diet and lifestyle medicine. Why is there a gap between this epidemic and more effective treatment? Dr. Bradley discusses his clinical research on feasible, cost-effective, efficacious interventions and wider topics around personalised whole person care and ‘disruptive innovation’ for health promotion.

Guest:

Dr. Ryan Bradley, ND, MPH

About our guest:

Dr. Bradley is an Associate Professor in the University of California, San Diego Herbert Wertheim School of Public Health and Human Longevity Science in La Jolla, CA. His commitment to research is to improve the health of the public through rigorous research on non-drug treatments. 

Dr. Bradley received his ND in naturopathic medicine from Bastyr University in 2003, and his MPH in Epidemiology from the University of Washington in 2009. He completed NIH-funded T32 research training in complementary medicine at Bastyr University and KL2 training in clinical research at the University of Washington in the Division of Cardiology.  

His research interests include clinical trials of natural products and mind-body therapies in chronic inflammatory conditions including heart disease, type 2 diabetes, pain, and inflammatory bowel disease, plus cardiovascular epidemiology related to natural products, e.g., cannabis, and heart disease risk.

Dr. Bradley has conducted a wide-variety of clinical and observational research, including: cardiovascular epidemiology in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort; observational research and clinical trials on practice outcomes from integrating naturopathic medicine and conventional medicine for type 2 diabetes and cardiovascular disease; clinical trials of natural products (including vitamin D, marine oils, xanthohumol, mixed-carotenoids, and quercetin) and mind-body interventions including qigong for type 2 diabetes. 

He has published in leading peer-reviewed medical journals including: Journal of Alzheimer’s Disease, Aging, Atherosclerosis, the Canadian Medical Association Journal, and the Journal of Clinical Endocrinology and Metabolism.

Guest website and links: 

https://www.researchgate.net/profile/Ryan-Bradley-7

Selection of our guest’s publications: 

• Harnett JE, Rickwood C, Steel A, Bradley R. Naturopathic practitioners’ approach to caring for people with cardiovascular disease risk factors: A cross-cultural cross-sectional study reporting the providers perspective. Complement Ther Clin Pract. 2022 Feb;46:101511.
• Anderson CAM, Bradley R. The potential of novel plant protein foods to improve dietary patterns and markers of cardiovascular health. Am J Clin Nutr. 2020 Nov 11;112(5):1151-1152.
• Steel A, Rickwood C, Bradley R, Foley H, Harnett JE. Australian Naturopaths’ Approach to Caring for People with Cardiovascular Disease and Associated Risk Factors: A Qualitative Study of the Providers’ Perspective. J Altern Complement Med. 2020 Oct;26(10):902-910.
• Bradley R, Harnett J, Cooley K, McIntyre E, Goldenberg J, Adams J. Naturopathy as a Model of Prevention-Oriented, Patient-Centred Primary Care: A Disruptive Innovation in Health Care. Medicina (Kaunas). 2019 Sep 18;55(9):603. doi: 10.3390/medicina55090603. PMID: 31540415; PMCID: PMC6780388.
• Seely D, Szczurko O, Cooley K, Fritz H, Aberdour S, Herrington C, Herman P, Rouchotas P, Lescheid D, Bradley R, Gignac T, Bernhardt B, Zhou Q, Guyatt G. Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial. CMAJ. 2013 Jun 11;185(9):E409-16.
• Neuendorf R, Corn J, Hanes D, Bradley R. Impact of Food Immunoglobulin G-Based Elimination Diet on Subsequent Food Immunoglobulin G and Quality of Life in Overweight/Obese Adults. J Altern Complement Med. 2019 Feb;25(2):241-248.